Vaxart (STU:NB11) Float Percentage Of Total Shares Outstanding: 99.76% (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:NB11 Vaxart Inc STU:NB11
63 GF Score
Price €0.60
GF Value €9.39
! 3 Warning Signs
View Full Analysis

What is Vaxart Float Percentage Of Total Shares Outstanding?

Vaxart STU:NB11 63 Float Percentage Of Total Shares Outstanding is 99.76% as of Jul. 18, 2026. GuruFocus rates STU:NB11 with a GF Score™ of 63/100 and a GF Value™ of €9.39. The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vaxart's float shares is 240.83 Mil. Vaxart's total shares outstanding is 241.40 Mil. Vaxart's float percentage of total shares outstanding is 99.76%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vaxart's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vaxart's Institutional Ownership is 0.07%.

STU:NB11
63GF Score
Vaxart Inc STU:NB11
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxart Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Vaxart's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=240.83/241.40
=99.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.76% mean?
Vaxart (STU:NB11) has a Float Percentage Of Total Shares Outstanding of 99.76% as of Jul. 18, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Vaxart and its competitors.
Is Vaxart's Float Percentage Of Total Shares Outstanding too high?
Vaxart's current Float Percentage Of Total Shares Outstanding is 99.76%. Overall, Vaxart has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Vaxart's Float Percentage Of Total Shares Outstanding compare to SPRO and ADCT?
Vaxart's Float Percentage Of Total Shares Outstanding of 99.76% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Vaxart and its competitors. Vaxart's current Float Percentage Of Total Shares Outstanding is 99.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxart stock overvalued right now?
Vaxart (STU:NB11) has a current Float Percentage Of Total Shares Outstanding of 99.76%. The stock's GF Value™ is €9.39, compared to a current price of €0.60 — trading 93.6% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 99.76%. Vaxart's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Vaxart (STU:NB11), the current Float Percentage Of Total Shares Outstanding is 99.76% as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaxart (STU:NB11) Overvalued in 2026?

Based on GuruFocus' analysis, Vaxart stock appears to be undervalued. The current stock price of €0.60 is trading 93.6% below its estimated GF Value™ of €9.39.

Key valuation signals for STU:NB11:

  • Float Percentage Of Total Shares Outstanding: 99.76%
  • GF Value™: €9.39 vs. price of €0.60 (93.6% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the STU:NB11 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vaxart Business Description

Other Exchanges VXRT:USA
Address 170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically, all the business activity functions through the region of the United States.
63GF Score

Get the complete analysis for STU:NB11

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.60
Price
€9.39
GF Value